Kaija Holli

Treatment of the terminal stages of breast cancer.

K. Holli, M. Hakama, Matti Hakama, 1989, BMJ.

Radiotherapy to regional nodes in early breast cancer: an individual patient data meta-analysis of 14 324 women in 16 trials

R. Gelber, A. Tutt, M. Piccart, 2023, The Lancet.

Safety and efficacy results of a randomized trial comparing adjuvant toremifene and tamoxifen in postmenopausal patients with node-positive breast cancer. Finnish Breast Cancer Group.

V. Kataja, K. Holli, H. Joensuu, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Combination chemotherapy versus single-agent therapy as first- and second-line treatment in metastatic breast cancer: a prospective randomized trial.

K. Holli, H. Joensuu, A. Aro, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intensity of diagnostic and treatment activities during the end of life of patients with advanced breast cancer

K. Holli, H. Huhtala, R. Asola, 2006, Breast Cancer Research and Treatment.

Adjuvant trials of toremifene vs tamoxifen: the European experience.

K. Holli, Kaija Holli, 1998, Oncology.

Effect of baseline oestradiol serum concentration on the efficacy of anastrozole for preventing breast cancer in postmenopausal women at high risk: a case-control study of the IBIS-II prevention trial.

B. Bonanni, Kim Chu, Steven R. Cummings, 2023, The Lancet. Oncology.

Tamoxifen and toremifene treatment of breast cancer and risk of subsequent endometrial cancer: A population‐based case‐control study

P. Kyyrönen, K. Holli, R. Sankila, 2002, International journal of cancer.